[ad_1] Chevron said it will book $3.5 billion to $4 billion in charges for the fourth quarter, citing challenges tied to regulations in California and previously sold oil and gas…
Tag: Physical Asset Transactions
KKR Purchases $7.2 Billion Portfolio of Prime RV Loans
[ad_1] KKR purchased a $7.2 billion portfolio of super-prime recreational vehicle loans from BMO Bank National Association. The alternative-asset manager said funds and accounts managed by its credit business led…
He Bought a Piece of the Chrysler Building. Now His Empire Is Falling Apart.
[ad_1] Nov. 29, 2023 11:05 am ET The property slump sweeping the globe has claimed a new high-profile victim: René Benko, an Austrian-born retail and department-store magnate who also co-owns…
Bay Area Estate Asks $16 Million More Than its 2020 Sale Price
[ad_1] A private-equity founder is asking $35 million for his Bay Area estate, just three years after buying it for $19 million. J. Taylor Crandall, a founder of private-equity firm…
UAW, Stellantis Reach Tentative Agreement on New Four-Year Labor Contract
[ad_1] Updated Oct. 28, 2023 2:11 pm ET The United Auto Workers has reached a tentative agreement with Chrysler-parent Stellantis on a new labor contract, moving the union one step…
Morgan Stanley’s James Gorman Picked a Good Time to Leave
[ad_1] Oct. 28, 2023 10:27 am ET James Gorman guided Morgan Stanley through years of superlow interest rates and booming stock markets. His successor, Ted Pick, might have to come…
Changing U.S. Stance Toward Venezuela Buoys Creditors
[ad_1] Oct. 27, 2023 1:36 pm ET|WSJ Pro The Biden administration’s rollback of sanctions against Venezuela is offering a helping hand to bondholders owed $63 billion from the government in Caracas, many…
Chevron and Exxon Might Have Kicked Off an Oil Land Grab
[ad_1] The smell of mergers and acquisitions is in the air following more than $110 billion worth of oil megadeals this month—Chevron’s agreement to buy Hess and Exxon Mobil’s deal…
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
[ad_1] The deal expands the pharmaceutical company’s portfolio of cancer drugs. [ad_2] Source link
The Brash Strategy That Made Vivek Ramaswamy a Fortune
[ad_1] Updated Sept. 9, 2023 10:51 am ET Vivek Ramaswamy was a novice biotech entrepreneur in 2016 with no advanced medical training and no record of developing drugs. Copyright ©2023…